MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Book Value per Share : ₺18.74 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Book Value per Share?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's book value per share for the quarter that ended in Dec. 2024 was ₺18.74.

During the past 12 months, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's average Book Value Per Share Growth Rate was 4.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 57.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 106.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of MEDITERA TIBBI MALZEMENAYI VE TICARET AS was 182.10% per year. The lowest was 57.60% per year. And the median was 116.15% per year.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current price is ₺29.06. Its book value per share for the quarter that ended in Dec. 2024 was ₺18.74. Hence, today's PB Ratio of MEDITERA TIBBI MALZEMENAYI VE TICARET AS is 1.55.

During the past 7 years, the highest P/B Ratio of MEDITERA TIBBI MALZEMENAYI VE TICARET AS was 8.33. The lowest was 1.55. And the median was 2.75.

Good Sign:

MEDITERA TIBBI MALZEME SANAYI VE TICARET AS stock PB Ratio (=1.58) is close to 5-year low of 1.58.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Book Value per Share Historical Data

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Book Value per Share Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Book Value per Share

Get a 7-Day Free Trial

1.83

4.79

12.66

17.89

18.74

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Book Value per Share	Get a 7-Day Free Trial															17.89	14.42	15.79	17.43	18.74

Competitive Comparison of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Book Value per Share

For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PB Ratio distribution charts can be found below:

* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's PB Ratio falls into.

Save Embed

;

Save Embed

;

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Book Value per Share Calculation

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2,230	-	0)	/	119
	=	18.74

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2,230	-	0)	/	119
	=	18.74

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Book Value per Share Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900

Website

https://www.meditera.com.tr

MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines